Clearstream Share Discussion Threads

[spaceparallax] 08/4/2011 16:47

A superb week's work - no doubt we'll benefit from some media attention this weekend that could see us really attain new heights next week.

[spaceparallax] 08/4/2011 13:13

Certainly if the growth forecasts prove accurate.

[hastings] 08/4/2011 13:11

Could well be S, but i think that should be somewhat insignificant 12 months on!!

[spaceparallax] 08/4/2011 11:12

Looks as if 60p could be broken very soon.

[spaceparallax] 08/4/2011 09:39

The healthy rebound continues

[spaceparallax] 07/4/2011 14:39

here we go again

[hastings] 07/4/2011 13:13

Well S, back in september around 47% were held by Institutions with notifiable stakes, that now stands around 56% and i guess there are others sitting below the 3% level.

[spaceparallax] 07/4/2011 13:08

Very enlightening - I didn't realise that we had so many fingers in the pie

[hastings] 07/4/2011 13:06

Interesting to see how Institutions have increased their holdings since listed on the header



ClearStream Technologies Group PLC
Shareholders

Shares in issue: 46.1m EUR0.125 Ords
Major Shareholders Amount % Holding
Legal & General Group PLC 6,100,000 13.24
Blackrock Inc 4,500,000 9.76
Michael David Love • 4,386,266 9.52
Gartmore Investment Ltd 3,147,676 6.83
Lloyds Banking Group PLC 3,093,260 6.71
ICC Venture Capital Fund 3,093,240 6.71
Andrew John Jones • 2,083,777 4.52
Enterprise Ireland 1,927,952 4.18
Williams de Broe Stockbrokers 1,830,500 3.97
Henderson Global Investors Ltd 1,710,000 3.71
Amati Global Investors Limited 1,625,000 3.53
Royal Bank Ventures Invts Ltd 1,513,649 3.28
Barclays Stockbrokers Ltd 1,460,207 3.17

[hastings] 07/4/2011 09:59

Off we go again S!

[spaceparallax] 07/4/2011 09:40

ProfPP sounds a useful non-exec to have aboard.

Great to see the share price looking so buoyant this morning.

[spaceparallax] 06/4/2011 12:54

One would expect so - it could take a few days, but hopefully we should reach beyond the previous high.

[hastings] 06/4/2011 12:44

Well, picked up some more this morning S.Like you, I expect this to nudge upwards again sooner rather than later.

[spaceparallax] 06/4/2011 12:24

It appears that the news hasn't reached the wider mkt, only modest trading this morning albeit now touching 50p - should yield a tick-up soon.

[spaceparallax] 05/4/2011 16:25

On the up once more - I wouldn't be surprised, over the coming weeks, to see that 48p placing price generate interest to take the share price above 60p.

[spaceparallax] 05/4/2011 13:59

Thanks H, will do.

[hastings] 05/4/2011 13:08

Good for you S. Pleased to see that they have taken advantage of the recent performance in the share price in order to strenghten the position. Repeating myself again, but sound growth for the future here and would have thought that we should be nearer the pound than 50p by end of the year.
Oh and S, take a look at GNG looks interesting, picked a few up;

[stegrego] 05/4/2011 12:58

So thats probably why the price has come off, to get shares away at 48p.
Good to see though.

[spaceparallax] 05/4/2011 12:44

Just grabbed another 10K@49.35

I envisage that we're likely to see some very bullish punditry and tips.

[spaceparallax] 05/4/2011 12:32

Superb news - really provides solid support at 48p. Good to see the Directors buying too.

[hastings] 03/4/2011 19:39

Thanks S, appreciated. CTN is an excellent mid-long term play despite having already rewarded those of us in at much lower levels.

[spaceparallax] 03/4/2011 14:08

I don't really see what you're so put out by.

[adamb1978] 03/4/2011 12:50

What utter dross that Edison report is!!

Thanks for posting it but, seriously, it amazes that people get paid for writing such garbage! No real insight, lots of copy/paste from results...anyone on these bards could have done better!

[spaceparallax] 03/4/2011 11:07

Here goes, extracts from Edison report:-


"Sales up but and margins steady
Period-on-period, co-labelling sales growth slowed to 13%, but revenues were still a record €4.6m. This is due to the success of the Sleek and Savvy catheters with Cordis and the March 2010 Bard launch. Cordis is now selling the over-the wire SLEEK in the US; products are also approved in Japan. The surprise was OEM: at €2.4m this rose significantly on H110's €1m. Own brand weakened to €2.2m (vs H110's €2.3m). This range has a high level of coronary products and Intrepide (high value) is off market while a production issue is resolved; sales will restart in Q211.
Profits: A slim €0.12m in H1, but still there
The margin, at 29% net of depreciation and amortisation (31% in gross cash terms), did not rise as much as expected. As new capacity beds in and Intrepide sales restart, we expect c 31% margins in H2. Costs were up: a 36% R&D boost to €1.1m with others rising 8% as business increased. The newly appointed CTO starts soon.
Financials: Rising margins and costs
We have increased growth projections slightly. These now indicate FY11 sales of €19-20m with up to €30m possible by 2013. Manufacturing capacity, needing extra capex, is being added to sustain this sales level. Margins may rise to c 35% by 2013.
Valuation: Value upside as revenues grow towards €30m
Projecting to FY13 (instead of 2012) and using a 10-15 fold multiple range raises our indicative value from 41p to a range of 68-97p. Key H2 value factors will be overall growth and net margin levels, which should rise to over 30%. The product and channel mix is now more diverse, reducing forecasting risk; co-labelling is crucial."